Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines.

Wang S, Mboudjeka I, Goguen JD, Lu S.

Vaccine. 2010 Feb 23;28(8):2011-9. doi: 10.1016/j.vaccine.2009.10.059.

2.

A yeast glycoprotein shows high-affinity binding to the broadly neutralizing human immunodeficiency virus antibody 2G12 and inhibits gp120 interactions with 2G12 and DC-SIGN.

Luallen RJ, Fu H, Agrawal-Gamse C, Mboudjeka I, Huang W, Lee FH, Wang LX, Doms RW, Geng Y.

J Virol. 2009 May;83(10):4861-70. doi: 10.1128/JVI.02537-08. Epub 2009 Mar 4.

3.

Levels of N-linked glycosylation on the V1 loop of HIV-1 Env proteins and their relationship to the antigenicity of Env from primary viral isolates.

Huang Z, Chou A, Tanguay J, Shen S, Mboudjeka I, Chou TH, Lu S, Wang S.

Curr HIV Res. 2008 Jun;6(4):296-305.

PMID:
18691028
4.

An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies.

Luallen RJ, Lin J, Fu H, Cai KK, Agrawal C, Mboudjeka I, Lee FH, Montefiori D, Smith DF, Doms RW, Geng Y.

J Virol. 2008 Jul;82(13):6447-57. doi: 10.1128/JVI.00412-08. Epub 2008 Apr 23.

5.

Relative immunogenicity and protection potential of candidate Yersinia Pestis antigens against lethal mucosal plague challenge in Balb/C mice.

Wang S, Joshi S, Mboudjeka I, Liu F, Ling T, Goguen JD, Lu S.

Vaccine. 2008 Mar 20;26(13):1664-74. doi: 10.1016/j.vaccine.2008.01.024. Epub 2008 Feb 4.

6.

Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E.

Wang S, Pal R, Mascola JR, Chou TH, Mboudjeka I, Shen S, Liu Q, Whitney S, Keen T, Nair BC, Kalyanaraman VS, Markham P, Lu S.

Virology. 2006 Jun 20;350(1):34-47. Epub 2006 Apr 17.

7.

Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype.

Pal R, Kalyanaraman VS, Nair BC, Whitney S, Keen T, Hocker L, Hudacik L, Rose N, Mboudjeka I, Shen S, Wu-Chou TH, Montefiori D, Mascola J, Markham P, Lu S.

Virology. 2006 May 10;348(2):341-53.

8.

Polyvalent DNA prime and envelope protein boost HIV-1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate.

Pal R, Wang S, Kalyanaraman VS, Nair BC, Whitney S, Keen T, Hocker L, Hudacik L, Rose N, Cristillo A, Mboudjeka I, Shen S, Wu-Chou TH, Montefiori D, Mascola J, Lu S, Markham P.

J Med Primatol. 2005 Oct;34(5-6):226-36.

9.
10.

Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).

Chou TH, Wang S, Sakhatskyy PV, Mboudjeka I, Lawrence JM, Huang S, Coley S, Yang B, Li J, Zhu Q, Lu S.

Virology. 2005 Mar 30;334(1):134-43. Erratum in: Virology. 2005 Jun 20;337(1):204. Mboudoudjeck, Innocent [corrected to Mboudjeka, Innocent].

11.
12.

Genetic subtypes of HIV type 1 based on the vpu/env sequences in the Republic of Congo.

Taniguchi Y, Takehisa J, Bikandou B, Mboudjeka I, N'Doundou-N'Kodia MY, Obengui, M'Pandi M, M'Pelé P, Harada Y, Ido E, Hayami M, Ichimura H, Parra HJ.

AIDS Res Hum Retroviruses. 2002 Jan 1;18(1):79-83.

PMID:
11804559
13.

Natural infection of wild-born mandrills (Mandrillus sphinx) with two different types of simian immunodeficiency virus.

Takehisa J, Harada Y, Ndembi N, Mboudjeka I, Taniguchi Y, Ngansop C, Kuate S, Zekeng L, Ibuki K, Shimada T, Bikandou B, Yamaguchi-Kabata Y, Miura T, Ikeda M, Ichimura H, Kaptué L, Hayami M.

AIDS Res Hum Retroviruses. 2001 Aug 10;17(12):1143-54.

PMID:
11522184
14.

The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region.

Barnett SW, Lu S, Srivastava I, Cherpelis S, Gettie A, Blanchard J, Wang S, Mboudjeka I, Leung L, Lian Y, Fong A, Buckner C, Ly A, Hilt S, Ulmer J, Wild CT, Mascola JR, Stamatatos L.

J Virol. 2001 Jun;75(12):5526-40.

15.

Genetic subtypes of HIV type 1 in Republic of Congo.

Bikandou B, Takehisa J, Mboudjeka I, Ido E, Kuwata T, Miyazaki Y, Moriyama H, Harada Y, Taniguchi Y, Ichimura H, Ikeda M, Ndolo PJ, Nzoukoudi MY, M'Vouenze R, M'Pandi M, Parra HJ, M'Pelé P, Hayami M.

AIDS Res Hum Retroviruses. 2000 May 1;16(7):613-9.

PMID:
10791871
16.

Genetic diversity of HIV-1 group M from Cameroon and Republic of Congo.

Mboudjeka I, Bikandou B, Zekeng L, Takehisa J, Harada Y, Yamaguchi-Kabata Y, Taniguchi Y, Ido E, Kaptue L, M'pelle P, Parra HJ, Ikeda M, Hayami M, Miura T.

Arch Virol. 1999;144(12):2291-311.

PMID:
10664385
17.

Natural infection of chimpanzees with new lentiviruses related to HIV-1/SIVcpz.

Takehisa J, Bikandou B, Ido E, Mboudjeka I, M'Vouenze R, Nzoukoudi MY, Harada Y, Yamaguchi-Kabata Y, Miura T, M'Pandi M, Parra HJ, M'Pelé P, Hayami M.

J Med Primatol. 1999 Aug-Oct;28(4-5):169-73.

PMID:
10593482
18.

HIV type 1 genetic variability in the northern part of Cameroon.

Mboudjeka I, Zekeng L, Takehisa J, Miura T, Ido E, Yamashita M, Kaptue L, Hayami M.

AIDS Res Hum Retroviruses. 1999 Jul 20;15(11):951-6.

PMID:
10445806
19.

Human immunodeficiency virus type 1 intergroup (M/O) recombination in cameroon.

Takehisa J, Zekeng L, Ido E, Yamaguchi-Kabata Y, Mboudjeka I, Harada Y, Miura T, Kaptu L, Hayami M.

J Virol. 1999 Aug;73(8):6810-20.

20.

Various types of HIV mixed infections in Cameroon.

Takehisa J, Zekeng L, Ido E, Mboudjeka I, Moriyama H, Miura T, Yamashita M, Gürtler LG, Hayami M, Kaptué L.

Virology. 1998 May 25;245(1):1-10.

21.

African origin of GB virus C/hepatitis G virus.

Tanaka Y, Mizokami M, Orito E, Ohba K, Kato T, Kondo Y, Mboudjeka I, Zekeng L, Kaptue L, Bikandou B, M'Pele P, Takehisa J, Hayami M, Suzuki Y, Gojobori T.

FEBS Lett. 1998 Feb 20;423(2):143-8.

22.

Prevalence and phylogenetic analysis of HTLV-I isolates in Cameroon, including those of the Baka Pygmy.

Mboudjeka I, Zekeng L, Yamashita M, Takehisa J, Ido E, Miura T, Ohkura S, Ikeda M, Kaptue L, Hayami M.

Jpn J Cancer Res. 1997 Jul;88(7):619-24.

23.

Triple HIV-1 infection with group O and Group M of different clades in a single Cameroonian AIDS patient.

Takehisa J, Zekeng L, Miura T, Ido E, Yamashita M, Mboudjeka I, Gürtler LG, Hayami M, Kaptue L.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jan 1;14(1):81-2. No abstract available.

PMID:
8989217
24.

HTLV type I isolated from a Pygmy in Cameroon is related to but distinct from the known central African type.

Chen J, Zekeng L, Yamashita M, Takehisa J, Miura T, Ido E, Mboudjeka I, Tsague JM, Hayami M, Kaptue L.

AIDS Res Hum Retroviruses. 1995 Dec;11(12):1529-31. No abstract available.

PMID:
8679297

Supplemental Content

Loading ...
Support Center